Not recruitingEUCTR 2022-003743-10
A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, with Open Label Extension, in Patients with Treatment Resistant Depression
This historical record does not confirm current site availability.
Historical research recordMultiple countries
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with depression. Other eligibility criteria apply.
- Listed locations
- Berlin and 15 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- 203
- Sponsor
- Beckley Psytech Ltd.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Germany, Poland, Spain
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2022-003743-10
- Official title
Show the full official title
A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, with Open Label Extension, in Patients with Treatment Resistant Depression
Recruitment & locations
Not recruitingBerlin, Germany · Frankfurt am Main, Germany · Mannheim, Germany
10 more locations
- Tuebingen, Germany
- Gdansk, Poland
- Lodz, Poland
- Tuszyn, Poland
- Warsaw, Poland
- Barcelona, Spain
- Esplugues De Llobregat, Spain
- Mostoles, Spain
- Oviedo, Spain
- Salamanca, Spain
Registry details
Original registry record (opens in a new tab)A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Beckley Psytech Ltd.
Who can participate?
This study is for people with depression. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy and tolerability of a fixed dose of BH-200 (250 mg BID) i...
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With ...